Skip to content

Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children

Phase 1 Study of Circadian Rhythm of Salivary Cortisol in Health Children ;Phase 2 Study of Circadian Rhythm of Salivary Cortisol of Children Undergoing Surgery Using Etomidate or Not Using Etomidate.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02013986
Enrollment
30
Registered
2013-12-17
Start date
2013-09-30
Completion date
2014-08-31
Last updated
2013-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Choledochal Cyst, Congenital Hydronephrosis, Fracture

Keywords

salivary cortisol, circadian rhythm, children, etomidate

Brief summary

Etomidate is an unique drug used for induction of general anesthesia and sedation. Adrenal cortical inhibition by etomidate has received much attention. However wether the circadian rhythm and pulse secretion pattern of cortisol in children are the same as that in adults is not known. Moreover, the effect of etomidate on circadian rhythm changes and clinical outcomes has never been carefully studied in children undergoing surgery. Our hypothesis is that etomidate can relieve the changes of circadian rhythm of salivary cortisol in children for 24-48 hours,and this does not make clinical outcomes worse postoperatively.

Detailed description

* Sample size assessment: Using formula to calculate the total number is 30. * Statistical analysis: ANOVA * Reporting for adverse events: During the period of study, if there is any severe adverse event happening, such as severe infection, severe low cortisol concentration threatening the patient's life we will stop the trial.

Interventions

DRUGetomidate

0.3mg/kg IV only once during induction of general anesthesia

DRUGmidazolam

midazolam 0.1mg/kg IV only once before using of etomidate/propofol during induction of general anesthesia

DRUGpropofol

2mg/kg IV only once during induction of general anesthesia

Sponsors

Du yi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* 3-12 years old who are plan to undergo surgery

Exclusion criteria

* endocrine disease, blood infusion, having fever, ulcer or bleeding in the oral cavity

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in salivary cortisol at the operative daybaseline(8am), 8pmAt the time of 8am(baseline) and at the time of 8pm in the operative day , get salivary samples to calculate the change of salivary cortisol
Change from baseline in salivary cortisol at the first day after surgerybaseline(8am), 8pmAt the time of 8am(baseline) and at the time of 8pm in the first day after surgery , get salivary samples to calculate the change of salivary cortisol

Secondary

MeasureTime frameDescription
Numbers of Acquired Infection Eventsup to 10 days after surgeryAcquired infection using extra antibiotics(not prophylactic antibiotics) after surgery.
Numbers of using inotropic drugswithin 3 daysInotropic drugs include norepinephrine, adrenaline, phenylephrine and dopamine.
Days of stay in intensive care unit (ICU) after surgeryup to 10 days after surgeryDays of stay in ICU after surgery.

Countries

China

Contacts

Primary ContactChen yijun
86-21-13764206966

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026